Home > Healthcare > Biotechnology > Biotechnology R&D > Non-animal Alternative Testing Market

Non-animal Alternative Testing Market Size

  • Report ID: GMI5704
  • Published Date: May 2023
  • Report Format: PDF

Non-animal Alternative Testing Market Size

Non-Animal Alternative Testing Market size was valued at USD 1.7 billion in 2022 and will progress tremendously to reach over USD 4.5 billion by 2032 at 10.3% CAGR. The high market growth is owing to the rising emphasis on animal welfare as part of global sustainable development goals.


Non-Animal Alternative Testing Market

To understand key trends  
Download Free Sample

While animal models are critical to biomedical research for drug and treatment developments, research agencies are encouraging the adoption of complementary approaches or alternatives to animal testing. Additionally, adoption of the 3R principles (replacement, reduction, and refinement) by both regulatory bodies and end-use industries, specifically in the field of pharmaceuticals is expected to drive the market for non-animal alternative testing during projection period.


Non-animal alternative testing are methods for replacing animals used in experiments such as clinical studies for drug development with algorithms and computational programs in order to avoid animal cruelty and maintain ethical practices while achieving maximum accuracy in experiments such as finding potential drug molecules.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market for non-animal alternative testing was valued at USD 1,725.0 million in 2022 and is expected to surpass USD 4,534.2 million by 2032 at 10.3% CAGR attributed to the rising emphasis on animal welfare.

The cell culture technology segment generated USD 746.9 million in 2022 and is anticipated to grow at a steady pace through 2032 owing to its extensive use by researchers for analyzing many test results simultaneously.

The North America non-animal alternative testing market amassed USD 653.8 million in 2022 and is poised to grow at 8.2% CAGR through 2032 due to the presence of key players in the region.

AlveoliX AG, MIMETAS, MatTek Corporation, Emulate, Inc, VITROCELL Systems GmbH, Bio-Rad Laboratories, Inc., Hurel Corporation, Evotec SE, MB Research Laboratories, and TissUse GmbH are the prominent companies in the market.

Non-animal Alternative Testing Market Scope

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Base Year: 2022
  • Companies covered: 11
  • Tables & Figures: 342
  • Countries covered: 20
  • Pages: 180
 Download Free Sample